Artificial Intelligence in Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Component, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Artificial Intelligence in Diagnostics Market size was worth USD 2.13 Billion in 2026 and is poised to grow at 21.93% CAGR between 2027 and 2036, crossing USD 15.47 Billion by 2036. The industry revenue for 2027 is assessed at USD 2.54 Billion.
Get more details on this report
Request Free Sample ReportArtificial Intelligence in Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 43.14% in 2026, supported by advanced healthcare infrastructure, digital health adoption, AI-enabled workflows, and favorable investment conditions.
- Asia Pacific is the fastest-growing region, driven by healthcare digitization, medical infrastructure investments, advanced imaging adoption, and demand for efficient diagnostic services.
Segment Momentum
- Software accounted for 62.01% of the market in 2026 and remains the fastest-growing component because it enables AI-powered image analysis, clinical decision support, predictive analytics, and workflow optimization across healthcare settings.
- Oncology is the fastest-growing application as healthcare providers increasingly use AI for cancer screening, diagnosis, treatment planning, and disease monitoring to support precision medicine and improve clinical outcomes.
Market Expansion Drivers
- Rising prevalence of chronic diseases increasing demand for diagnostic AI solutions
- Increasing demand for AI tools enhancing clinical decision support capabilities
- Integration of imaging AI into radiology workflows improving diagnostic accuracy and speed
Leading Market Participants
- Key players in the artificial intelligence in diagnostics market include Aidoc Ltd. (Israel), AliveCor, Inc. (United States), Digital Diagnostics Inc. (United States), Enlitic, Inc. (United States), HeartFlow, Inc. (United States), PathAI, Inc. (United States), Qure.ai Technologies Pvt. Ltd. (India), Siemens Healthineers AG (Germany), NVIDIA Corporation (United States), Tempus Labs, Inc. (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.13 Billion
- 2027 Estimated Market Size: USD 2.54 Billion
- Projected Market Size: USD 15.47 Billion by 2036
- Growth Forecast: 21.93% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Software (Component) | Radiology (Application) | Diagnostic Laboratories (End-use)
- Emerging Opportunity Segment: Software (Component) | Oncology (Application) | Diagnostic Laboratories (End-use)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic diseases increasing demand for diagnostic AI solutions
The growing incidence of chronic diseases, including cardiovascular disorders, cancer, diabetes, and neurological conditions, is increasing the volume and complexity of diagnostic procedures performed across healthcare systems. The artificial intelligence in diagnostics market growth is driven by the need for intelligent solutions that can assist clinicians in analyzing large datasets, identifying disease patterns, and supporting earlier diagnosis. Healthcare providers are also adopting AI-enabled diagnostic platforms to manage rising patient workloads while improving consistency and efficiency in clinical assessments.
Increasing demand for AI tools enhancing clinical decision support capabilities
Healthcare organizations are increasingly integrating artificial intelligence into clinical workflows to strengthen decision-making and improve diagnostic confidence. This trend will propel the artificial intelligence in diagnostics market growth as AI-powered tools provide clinicians with evidence-based insights, prioritize critical cases, and assist in interpreting complex medical information from multiple data sources. These capabilities support more informed treatment planning while helping healthcare professionals reduce variability in diagnostic evaluations across diverse clinical settings.
Integration of imaging AI into radiology workflows improving diagnostic accuracy and speed
Radiology departments are incorporating artificial intelligence into imaging workflows to enhance interpretation efficiency and accelerate reporting without compromising diagnostic quality. The artificial intelligence in diagnostics market benefits from this transition as AI algorithms assist in detecting abnormalities, highlighting suspicious findings, and streamlining image analysis across modalities such as computed tomography, magnetic resonance imaging, and X-ray systems. Workflow integration also enables radiologists to manage increasing imaging volumes more effectively while improving prioritization of urgent examinations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic diseases increasing demand for diagnostic AI solutions | 2.5% | High | North America, Europe | High | Mid Term |
| Increasing demand for AI tools enhancing clinical decision support capabilities | 2.7% | High | Asia Pacific, North America | High | Near Term |
| Integration of imaging AI into radiology workflows improving diagnostic accuracy and speed | 2.6% | High | Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the artificial intelligence in diagnostics market at 43.14% in 2026. The region benefits from advanced healthcare infrastructure, strong adoption of digital health technologies, and increasing integration of artificial intelligence into diagnostic workflows. Healthcare providers are increasingly using AI-enabled tools to support image analysis, disease detection, clinical decision-making, and workflow efficiency. Favorable investment conditions, a strong focus on healthcare innovation, and growing demand for faster and more precise diagnostic processes are supporting continued adoption across hospitals, diagnostic centers, and other healthcare settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing region in the artificial intelligence in diagnostics market, supported by expanding healthcare digitization and increasing demand for accessible and efficient diagnostic services. Rising healthcare needs, investments in medical infrastructure, and the adoption of advanced imaging and data-driven clinical technologies are creating opportunities for AI-based diagnostic solutions. The region is also witnessing greater interest in automation and technology-enabled healthcare delivery, particularly where AI can help improve diagnostic efficiency and extend specialist capabilities across diverse healthcare systems.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Clinical Decision SupportThe U.S. artificial intelligence in diagnostics market is advancing through healthcare providers integrating AI into imaging, pathology, and clinical workflows. Healthcare organizations prioritize solutions that improve diagnostic consistency, accelerate interpretation, and complement clinician expertise across multiple specialties.
Germany 🇩🇪
Precision Diagnostic IntegrationGermany emphasizes artificial intelligence in diagnostics that enhances clinical precision while fitting established healthcare workflows. Hospitals and diagnostic centers increasingly evaluate AI tools that improve image interpretation, support physicians, and streamline diagnostic decision-making processes.
Japan 🇯🇵
Imaging Workflow EnhancementJapan focuses on artificial intelligence in diagnostics to address growing demand for efficient medical imaging interpretation. Healthcare providers increasingly adopt AI-enabled diagnostic platforms that reduce reporting time while supporting accurate evaluation across high-volume clinical settings.
South Korea 🇰🇷
Digital Healthcare AccelerationSouth Korea continues integrating artificial intelligence into diagnostics through digitally connected healthcare ecosystems. Medical institutions invest in AI solutions that assist disease detection, improve workflow efficiency, and strengthen collaboration between diagnostic technologies and healthcare professionals.
France 🇫🇷
Integrated Clinical AnalyticsFrance is expanding the use of artificial intelligence in diagnostics by incorporating advanced analytics into routine clinical practice. Healthcare providers seek interoperable AI platforms that enhance diagnostic confidence while supporting efficient patient management across diverse care environments.
Italy 🇮🇹
Diagnostic Workflow OptimizationItaly is adopting artificial intelligence in diagnostics to improve efficiency within imaging departments and laboratory services. Healthcare organizations prioritize AI applications that support faster clinical assessments while integrating smoothly with existing diagnostic infrastructure and hospital information systems.
Segment Leadership and Growth Trends
Artificial Intelligence in Diagnostics Market Share (%), by Component, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportComponent Segment Analysis: Software (Largest & Fastest-Growing Segment)
The software segment dominated the artificial intelligence in diagnostics market, accounting for 62.01% of the market share in 2026, and is also expected to remain the fastest-growing component. Software platforms serve as the foundation for AI-driven diagnostic capabilities by enabling image analysis, clinical decision support, predictive analytics, and workflow optimization. Continuous advancements in artificial intelligence algorithms, greater integration with healthcare information systems, and increasing demand for automated diagnostic tools are strengthening software adoption across healthcare settings. The expanding focus on improving diagnostic accuracy and operational efficiency is expected to sustain the segment’s strong momentum.
Application Segment Analysis: Radiology (Largest Segment) vs Oncology (Fastest-Growing Segment)
The radiology application segment held the largest share, accounting for 30.67% in 2026. Its leadership is driven by the extensive use of artificial intelligence for interpreting medical imaging, improving image quality, assisting in early disease detection, and reducing diagnostic workloads for radiologists. The growing volume of imaging procedures and increasing emphasis on faster, more accurate clinical decision-making continue to support widespread adoption of AI solutions in radiology.
In the artificial intelligence in diagnostics market, the oncology application segment is expected to experience the fastest growth as healthcare providers increasingly leverage AI to support cancer screening, diagnosis, treatment planning, and disease monitoring. Advancements in data analysis, precision medicine, and personalized treatment approaches are enhancing the value of AI in oncology. Rising demand for early cancer detection and improved clinical outcomes is further accelerating adoption within this application area.
End-use Segment Analysis: Diagnostic Laboratories (Largest & Fastest-Growing Segment)
The diagnostic laboratories segment held the largest share of the market in 2026 and is also expected to be the fastest-growing end-use segment. Diagnostic laboratories increasingly rely on artificial intelligence to improve testing accuracy, automate complex analytical processes, optimize laboratory workflows, and manage growing testing volumes. The expanding adoption of data-driven diagnostics, combined with the need for faster and more reliable clinical results, continues to strengthen the role of AI within laboratory operations. Ongoing investments in advanced diagnostic technologies and laboratory modernization are expected to further support the segment’s sustained growth.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Component | Software, Services, Hardware | Software | Software |
| Application | Radiology, Oncology, Cardiology, Neurology, Pathology, Infectious Diseases, Others | Radiology | Oncology |
| End-use | Hospitals & Clinics, Diagnostic Laboratories, Imaging Centers, Others | Diagnostic Laboratories | Diagnostic Laboratories |
Competitive Landscape and Market Positioning
Leading companies in the artificial intelligence in diagnostics market:
- Aidoc Ltd. (Israel)
- AliveCor, Inc. (United States)
- Digital Diagnostics, Inc. (United States)
- Enlitic, Inc. (United States)
- HeartFlow, Inc. (United States)
- PathAI, Inc. (United States)
- Qure.ai Technologies Pvt. Ltd. (India)
- Siemens Healthineers AG (Germany)
- NVIDIA Corporation (United States)
- Tempus Labs, Inc. (United States)
Clinical adoption is steadily shifting competitive priorities in the artificial intelligence in diagnostics market toward solutions that demonstrate reliable integration with existing diagnostic workflows and produce results that clinicians can interpret with confidence. Developers are increasingly refining algorithms for real-world usability, emphasizing transparency, workflow compatibility, and consistent performance across varied clinical settings rather than focusing solely on algorithmic sophistication. As regulatory scrutiny and clinical validation expectations continue to rise, market participants are investing more heavily in evidence generation, interoperability, and implementation support, making trust and practical deployment capabilities central to competitive positioning.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Aidoc Ltd. (Israel) | |||||||
| AliveCor Inc. (United States) | |||||||
| Digital Diagnostics Inc. (United States) | |||||||
| Enlitic Inc. (United States) | |||||||
| HeartFlow Inc. (United States) | |||||||
| PathAI Inc. (United States) | |||||||
| Qure.ai Technologies Pvt. Ltd. (India) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| NVIDIA Corporation (United States) | |||||||
| Tempus Labs Inc. (United States) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| SPARK | Nov-25 | SPARK partnered with Aster DM Healthcare to launch a joint research initiative focused on advancing AI-driven healthcare innovation. The collaboration focuses on developing AI-enabled clinical and diagnostic solutions to enhance patient care accuracy. |
| Roche | Sep-24 | Roche expanded its digital pathology platform by integrating over 20 advanced AI algorithms from eight new partners. The strategic collaboration strengthens diagnostic accuracy and research efficiency for pathologists and clinicians in cancer diagnosis. |
| GE HealthCare | Jul-24 | GE HealthCare partnered with AWS to integrate industry-specific AI foundation models and applications into clinical workflows. The collaboration leverages advanced cloud intelligence to unlock patient insights and enhance clinical decision-making capabilities. |
| NeuraSignal | Oct-23 | NeuraSignal acquired NovaSignal, the developer of the NovaGuide system. This acquisition integrates an autonomous, robot-assisted transcranial Doppler system into NeuraSignal's portfolio, expanding clinician access to automated data acquisition for right-to-left shunt detection. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Artificial Intelligence in Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Diagnostic Workflow Stage | Image & Data Acquisition, Image & Data Analysis, Clinical Interpretation, Diagnosis & Risk Assessment, Treatment & Follow-Up Support |
| Regulatory Status | Research-Use AI Solutions, Non-Regulated Clinical Decision Support, Regulated Diagnostic AI, AI-Based Medical Devices |
| Business Model | Software Licensing, Subscription-Based, Usage-Based, Platform-Based, Managed AI Services |
Artificial Intelligence in Diagnostics Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Pathways for AI Diagnostics |
|
| Diagnostic AI Evidence & Validation Landscape |
|
| Reimbursement Readiness for AI Diagnostics |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the artificial intelligence in diagnostics market generate?
What is the forecasted size of the artificial intelligence in diagnostics industry?
How is artificial intelligence strengthening diagnostic decision-making in healthcare?
Why is AI integration into radiology workflows gaining momentum?
Why does the software segment lead the artificial intelligence in diagnostics market?
Which application segment is growing the fastest in the artificial intelligence in diagnostics market?
What gives North America a strong position in AI diagnostics?
Why is Asia Pacific emerging as a high-momentum region for AI diagnostics?
What are the prominent companies operating in the artificial intelligence in diagnostics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization